Takeda, U.S.-Based Watson Settle Patent Battle Over Actos Generic
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals and generics maker Watson Pharmaceuticals of the United States settled a patent dispute over a copy of Takeda's Actos (pioglitazone) diabetes drug